English
Shukra Pharmaceuticals Q3 Results
- BSE: 524632
- NSE: -
- ISIN: INE551C01044
- Sector: Biotechnology & Drugs
BSE
48.30
-2.54 (-5.00%)
-2.54 (-5.00%)Volume1.43 L
Updated: Tue 20 Jan, 2026 | 09:05:45
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 24
Note: Comparison is on QoQ basis
Quarterly - Shukra Pharmaceuticals Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 7.34 | 5.59 | 31.47% | 9.86 | -25.49% |
| Depreciation/ Amortization | 0.70 | 0.70 | -0.06% | 0.51 | 36.37% |
| Operating Income | 3.24 | -0.03 | 0.00% | 9.03 | -64.13% |
| Net Income | 3.16 | 0.54 | 487.18% | 9.42 | -66.42% |
| Other Operating Expenses Total | 1.14 | 1.08 | 5.85% | 0.72 | 58.94% |
| Net Income Before Taxes | 4.09 | 0.87 | 368.03% | 9.53 | -57.03% |
| Total Revenue | 10.58 | 5.56 | 90.53% | 18.89 | -43.97% |
| Selling/ General/ Admin Expenses Total | 1.55 | 1.43 | 8.34% | 1.35 | 14.55% |
| Diluted Normalized EPS | 0.07 | 0.01 | 484.89% | 0.22 | -66.55% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.